Skip to main content

Table 3 Prognosis of bronchiectasis patients with airway limitations

From: The characteristics and prognosis of bronchiectasis patients with airflow limitation: a prospective longitudinal study

 

No airflow limitation

Airflow limitation

Airflow limitation

Three- groups analysis

No airflow limitation vs.

Airflow limitation

Mild-to-moderate

Severe

p value

p value

Subject n

83

47

37

84

  

Mortality

2.41

8.51

8.11

8.33

0.237

0.0901

Number of acute exacerbations 12 months after enrolment

1.46 ± 0.83

1.72 ± 1.25

1.81 ± 0.91

1.76 ± 1.10

0.0263

0.013

Number of hospitalizations 24 months after enrolment

1.10 ± 0.30

1.28 ± 0.50

1.46 ± 0.84

1.36 ± 0.67

0.0087

0.0016

Total number of hospitalizations from enrolment to the end of follow-up

1.34 ± 0.77

1.55 ± 0.97

2.11 ± 2.25

1.80 ± 1.67

0.1336

0.0421

Exacerbation duration

8.69 ± 3.78

12.77 ± 15.29

13.53 ± 12.63

13.11 ± 14.03

0.0696

0.0171

  1. The data are presented as the means ± SDs or percentages, except for the mortality rate, which is expressed as a percentage. The three-group analysis included no airflow limitation, mild-to-moderate airflow limitation and severe airflow limitation